Aurobindo Pharma informs about press release
Date: 15-09-2026Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with receipt of USFDA Final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg.
The above information is a part of company’s filings submitted to BSE.